Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Second-generation activated protein C resistance (APC-R) assay was developed to avert interferences from lupus anticoagulant (LA) and warfarin therapy by prediluting the patient sample with factor V (FV)-depleted plasma. We investigated the effect of LA on the second generation APC-R assay in 121 LA-positive patients. Twenty-five APC-R-positive patients were tested for the mutation in FV (Leiden, Hong Kong, and Cambridge). Eleven had FV Leiden and twelve were negative for any mutation (2 were not tested). Of 12, 8 had APC-R suggestive of heterozygous and 4 had APC-R suggestive of homozygous defects. These patients had strong LA activity, compared to those with concurrent FVL. This was associated with a trend toward increased thrombosis risk compared to those with normal APC-R. These findings suggest that LA causes acquired APC-R, reflecting an in vivo pathophysiologic effect of LA rather than merely an in vitro phenomenon even with the second generation APC-R assay.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/1076029610395571 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Age period cohort analysis of cancer incidence from 1990 to 2019 in Türkiye.
Cancer Epidemiol
June 2025
Dokuz Eylul University, Faculty of Medicine, Department of Public Health, Division of Epidemiology, Izmir, Turkey.
Background: Cancer is a major public health concern worldwide and in Türkiye, as it is one of the leading causes of disability-adjusted life years (DALYs) and mortality. This study aims to analyze long-term cancer trends in Türkiye from 1990 to 2019 using the Age-Period-Cohort (APC) model to determine the independent effects of aging, time periods, and birth cohorts on cancer incidence.
Methods: Cancer incidence data for all cancers and the most common site-specific cancers in men and women were obtained from the Global Burden of Disease 2021 study.
Factor V Leiden-independent activated protein C resistance: Communication from the plasma coagulation inhibitors subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation Committee.
J Thromb Haemost
January 2023
Laboratory Corporation of America Holdings, Burlington, North Carolina, USA.
Activated protein C resistance (APC-R) due to the single-nucleotide polymorphism factor V Leiden (FVL) is the most common cause of hereditary thrombophilia. It is found predominantly in Caucasians and is uncommon or absent in other populations. Although FVL is responsible for >90% of cases of hereditary APC-R, a number of other F5 variants that also confer various degrees of APC-R and thrombotic risk have been described.
View Article and Find Full Text PDFStudy on the Correlation between the Prevalence of Venous Thromboembolism in Kazak Pregnant and Lying-In Women in Xinjiang.
Contrast Media Mol Imaging
August 2022
Department of Vascular Surgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China.
In order to reveal the correlation between the prevalence of venous thromboembolism in Kazak pregnant and lying-in women in Xinjiang, the polymorphisms in the promoter region and coding region of the TAFI gene and the interaction of environmental factors are investigated. In this study, determination and analysis of anticoagulation indexes are conducted. The activity of antithrombin III and protein C is measured by chromogenic substrate method, and the activity of protein S is measured by coagulation method.
View Article and Find Full Text PDFAntiphospholipid syndrome: Reversal of antiphosphatidylserine/prothrombin-induced activated protein C resistance.
Thromb Res
October 2022
Thrombosis Research Laboratory, University of Padova, Padova, Italy; Arianna Foundation on Anticoagulation, Bologna, Italy. Electronic address:
Background: Anti-phosphatidylserine/prothrombin (aPS/PT) antibodies are the major contributor to activated Protein C resistance (APC-R) in tetra-positive thrombotic high-risk patients with Antiphospholipid Syndrome (APS).
Objectives: To evaluate the role of phospholipids (PL) on aPS/PT mediated APC-R.
Patients/methods: Total IgG were purified from plasma of 6 tetra-positive patients and IgG aPS/PT were affinity-purified from 3 of these patients.
Inherited and acquired thrombophilia in women of Indian ethnicity with recurrent pregnancy loss: An observational study from North India.
Indian J Pathol Microbiol
February 2022
Department of Hematology, AIIMS, New Delhi, India.
Objectives: The spectrum of thrombophilia in women with recurrent pregnancy loss (RPL) is different in Indian ethnicity as reported by few studies. We aimed to study the prevalence of thrombophilia in RPL patients referred to hematology department of a tertiary centre.
Material And Methods: This is an observational study of 112 RPL patients with no apparent cause after extensive workup for non-hematological causes.